OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

← The Rosemere Cancer Foundation

2025-03-31-accounts

J3rosemere CANQIR FOUN DA TION Reg Chaniy No 1131583 Annual Report & Accounts 2024/2025

Annual Report 2024/2025

Contents

3 Chair’s welcome

8 Your Support - our achievements and performance

11 Our fundraising practices

16 Structure, Governance and Management 16 Structure

16 Charitable Funds Committee 17 Rosemere Management Committee 17 The Funds

17 Connected Parties and Linked Charities

17 Risk Management and Internal Controls 18 Principal risks and uncertainty facing the Foundation 18 Internal Control 19 Trustee and Advisors and Contact Details for the Foundation

23 Going Concern 23 Reserves Policy 23 Investment Policy

30 Parent Balance Sheet as at 31 March 2025 31 Consolidated Cash Flow Statement for the year ended 31 March 2025

2

Annual Report 2024/2025

Chair’s welcome

It’s now been two years since I took on the role of Chairman here at Rosemere Cancer Foundation, after actively fundraising and volunteering for the cause for many years.

Throughout this time, I have been continuously awestruck at the lengths that our supporters will go to to raise funds for Rosemere. I’ve seen feats of strength and endurance; individuals holding hugely successful events year on year; people raising funds using their skills and talents, from sewing to singing; and people giving up their time, on a regular basis, to volunteer.

I’m truly honoured and humbled to witness the dedication and compassion that Rosemere supporters have – often for very personal reasons of their own. I know the Rosemere charity team are also ever so grateful for the income generated through our corporate supporters, who continue to recognise the importance of our work in the local area.

This kindness and commitment has resulted in us seeing another successful year for Rosemere Cancer Foundation – a year that saw the Rosemere Cancer Centre becoming one of the country’s first Surface Guided Radiotherapy Treatment centres of excellence thanks to the kindness of our supporters.

Alongside this, we funded many more innovative, life-changing projects in this year using the charitable funds that you have so kindly raised for us, so please read on to see the difference you have made.

Thank you John Hodgson,

Chair

Rosemere Cancer Foundation supports world class cancer treatment throughout Lancashire and South Cumbria. Our aim is to work in partnership with local clinical staff to achieve the best possible care for cancer patients across the region wherever they are treated. We seek to do this by:

We would like you to support us in our crucial work so please read on and let us tell you more about ourselves, what we do, what we have achieved and how we go about spending the money given to us.

Annual Report 2024/2025

Our aims and objectives

Under the Charities Act there are 13 descriptions of charitable purpose. The Foundation is covered by

“the advancement of health or the saving of lives”

We have referred to the guidance contained in the Charity Commission’s general guidance on public benefit when reviewing our aims, objectives and in planning our future activities. In particular the Trustee considers how planned activities will contribute to the aims and objectives they have set.

Our Foundation’s purposes as set out in the objects contained in the Foundation’s Trust Deed are to:

Support the provision of cancer services for the benefits of patients in Lancashire and South Cumbria

The objective use of charitable funds are defined in the Trust Deed as:

The Trustee shall use the Fund for any charitable purpose or purposes relating to the National Health Service

By raising additional funds and through the careful management of our existing funds, the Foundation provides a public benefit by making grants to support projects for the benefit of cancer patients. The Foundation funds projects not only at the Rosemere Cancer Centre, based at Royal Preston Hospital, but at cancer units across Lancashire and South Cumbria, supporting the four NHS Hospital Trusts that run eight hospital sites. As well as Preston, these are: Royal Blackburn Hospital, Blackpool Victoria Hospital, Burnley General Hospital, Chorley and South Ribble Hospital, Furness General Hospital, Royal Lancaster Infirmary and Westmorland General Hospital.

Wherever patients from Lancashire and South Cumbria are treated, there are projects at these sites funded by The Rosemere Cancer Foundation which are making a real difference to their comfort, wellbeing and quality of treatment. The granting of funds is made in accordance with charity law, our constitution and the wishes and directions of donors.

In making grants, we endeavour to reflect the wishes of patients and staff by directing funds towards areas they tell us are most in need. During the year 2024/25, grants totalling £1,122m were made.

Annual Report 2024/2025

How to support us

Get Involved

For details on volunteering opportunities, our events or to let us know what you have planned, please visit www.rosemere.org.uk, email rosemere@lthtr.nhs.uk or call the fundraising team on 01772 522913.

Making a Donation

To make a donation online please visit

www.rosemere.enthuse.com/donate

Gifts in Memory

Many thousands of pounds are given each year to the charity in memory of friends and family who have sadly passed away. These funds really help us to improve facilities, fund research or buy extra equipment that will benefit our patients, creating something very positive out of a sad personal loss.

Legacy Support

Gifts left to the Charity in a Will provide a valuable income source that help us fund vital work across the region ensuring that we continue to make a difference. It also allows us to plan for the future, benefitting as many patients as possible. Even the smallest legacy can have a lasting impact.

Gift Aid

Is the gift that keeps on giving and last year we claimed thousands of pounds in Gift Aid. If you are a UK tax payer and sign up for Gift Aid with us, we are able to claim an additional 25p for every £1 you donate.

6

Annual Report 2024/2025

Get In Touch

For information about events, Gift Aid, legacy donations and the many other ways you may wish to support, please visit www.rosemere.org.uk, email rosemere@lthtr.nhs.uk or call the fundraising team on 01772 522913. We would love to hear from you.

7

Our Walk in the Dark, our Cross Bay Walk, and our Walk the Lights events were great successes once again, with over 1,100 participants across all three of these flagship events, raising approximately £80,000 between them through entry fees, sponsorship and donations.

We added a new challenge event to our fundraising calendar in the form of Born Survivor, a 10k obstacle course, which we purchased charity places for. This proved to be very popular with our fundraisers and our team of participants raised almost £12,000 between them in sponsorship. We also returned to The Parish Church of St John Baptist, Broughton, for our second Christmas Carol Concert, which raised £2,000.

A large number of third-party fundraising events were held for us, and we saw the return of a number of established events that were once again successful. These included the return of Lytham Car Show, which raised approximately £24,000 (it’s greatest amount to date), The Taps Bike Ride which raised over £4,000, and the Ribble Valley Ride, from which we also received £4,000. We had 25 runners take part in the 2024 Great North Run, who collectively

Annual Report 2024/2025

raised £12,600 for us, and we received an incredible donation of £19,000 from the Keswick to Barrow Committee following May’s Keswick to Barrow Walk.

Charitable Trust activity continued to perform well over this last financial year, and we were delighted to receive grants of £40,000 from a number of different trusts.

These included the donation of £4,333 from The Rhodi Charitable Trust and the HVM Foundation to purchase a specialist chemotherapy chair, £7,559 from The Morrisons Foundation to support the introduction of stomafriendly accessible toilets across Royal Preston and Chorley and South Ribble Hospitals, and £8,000 from Morrisons Community Spaces Fund to help fund complementary therapies for patients and carers at Lancashire Teaching Hospitals. We also received two separate grants to support the provision of free-of-charge refreshments for patients and carers at the Lancashire Breast Unit - £500 from the Duchy of Lancaster Benevolent Fund, and £350 from Risley Medical, Research & Charity Trust Fund.

Supporter stewardship and engagement remains at the heart of what we do, with a real focus on supporting and thanking our fundraisers, and promoting our work through our regular newsletter, press releases, e-newsletters and other digital channels, Impact Report, end-of-year Thank You mailer and thank you event.

The Foundation is extremely thankful to the many people who have given generously throughout the year. The donations and legacies we receive are an invaluable source of funds used to purchase additional equipment and services, and support life-changing oncology-related projects that cannot be provided by core NHS funds.

Annual Report 2024/2025

Income received

The Foundation can only continue to support the work of hospitals in the region as long as we continue to receive the money needed to further our charitable aims and objectives.

The following chart illustrates the breakdown of our total income of £1,797,000 (2023/24: £1,492k) received in this financial year:

----- Start of picture text -----
Legacies: 36% Charitable Activities: 29%
Donations: 28% Investments: 2%
Trusts/Grants: 2%
Trading Activities: 2%
----- End of picture text -----

Our total legacy income in 2024/25 came to £787k (2023/24: £416k). As a charity, we truly appreciate the kindness of those who choose to leave a gift in their Will to us; any gift, no matter the amount, will make a real difference to the treatment and care of local cancer patients in Lancashire and South Cumbria for years to come.

Investment income for 2024/25 was £37k, (2023/24: £30k) in the form of dividends and bank interest as we managed funds not immediately required. The 2024/25 accounts for the Rosemere Coffee Shop Ltd, the coffee shop based within the Rosemere Cancer Centre and managed by a team of volunteers, generated a profit of £41k to be gift aided to the Charity.

The Coffee Shop team, which consists solely of volunteers, works tirelessly to support cancer patients, visitors and staff – and in turn, the Foundation itself – through their regular cafe service, selling refreshments and snacks at the Coffee Shop within the radiotherapy department at the Rosemere Cancer Centre, and donating all profits to the cause.

Our income from “donations” came to £1,189,000, and is made up of general donations from supporters, including corporate supporters, as well as payroll giving, in memory donations, and the cost equivalent of gift in kind donations.

“Charitable activities” income came to £527k and includes our own events (such as our annual Cross Bay Walk, Walk in the Dark, and Walk the Lights), challenge events such as the Great North Run, and community events and activity.

Annual Report 2024/2025

Our fundraising practices

Members of our fundraising team organise and co-ordinate fundraising activities on behalf of the charity and also support third-party fundraisers in organising their own events and initiatives to raise funds for us, both at our hospital trust, trusts across the region, and across the wider community.

We do not use external professional fundraisers or involve commercial participators. There have been no complaints about fundraising activity this year.

The Foundation is registered with the Fundraising Regulator’s Code of Fundraising Practice and fundraising staff attend relevant training sessions and seminars to ensure our fundraising practices are safe, proper and effective. All staff follow the fundraising guidance policy and working practices that are reviewed regularly to ensure compliance. They are also required to undertake relevant safeguarding mandatory training to help to recognise and protect vulnerable people.

Volunteer fundraisers are given a full briefing and appropriate training before they raise funds for us, and they are also given regular updates and reminders. All direct marketing is undertaken by the fundraising team in line with GDPR regulation, to ensure that it is both legal and not unreasonably intrusive or persistent. Contact is made through targeted marketing, usually on a quarterly basis subject to appeals. All marketing material contains clear instructions on how a person can be removed from mailing lists should they wish to do so.

Annual Report 2024/2025

Our largest area of spend was on grants for medical equipment, which totalled over £800k.

How we spend charitable funds

Of 2024/25’s total expenditure of £1,526k (2023/24: £1,511k), the amount spent on charitable activities, was £1,237k (2023/24: £1,245k)

Charitable activities spend covers a wide range of programmes from major capital projects to the purchase of medical equipment, the support of patient welfare projects both small and large, the provision of additional training for oncology staff across the region, and local clinical research. Checks are in place to ensure that all expenditure is in line with the NHS Standing financial instructions and in support of our charitable objectives, i.e. monies spent are used to purchase additional goods and services not normally provided by, or in addition to, the normal NHS service.

Our charity’s Management Committee and the Trust Charitable Funds Committee keeps the spirit of public benefit at the forefront of its decision making. The following chart illustrates the breakdown of the total expenditure in the financial year:

The bulk of this spend was a further £405,000 towards completing the roll-out of Surface Guided Radiotherapy Treatment at the Rosemere Cancer Centre, following on from our initial funding of £1.3m raised in the 2022/23 financial year through our successful 25th Anniversary Guiding Light Appeal. This extra funding means that all eight treatment rooms are now SGRT compliant, leading to Royal Preston Hospital becoming one of the country’s first Surface Guided Radiotherapy Treatment centres of excellence.

Lancashire Teaching Hospitals NHS Trust is also, thanks to our charitable support, the first centre in the region to introduce robotic TAMIS (Transanal Minimally Invasive Surgery): a cutting-edge approach to treating early-stage rectal cancer and complex polyps while preserving the rectum. The procedure uses the Da Vinci surgical robot (originally funded by us through our 2017/18 20th Anniversary Appeal) and a brand new robotic motion table, which was purchased with almost £300,000 from our charitable funds in this financial year.

The ‘medical equipment’ spend also included a grant to purchase a state-of-the-art ultrasound machine with specialist imaging software for ultrasound department at Royal Preston Hospital’s Sharoe Green Unit - kit which has been shown to have a far superior rate of ovarian cancer detection than standard, and will result in suspected ovarian cancer patients from the local area receiving a faster diagnosis.

We also supported Blackpool Victoria Hospital’s endoscopy clinic with the purchase of a specialist guide to make endoscopy procedures more comfortable while a smaller (but still impactful) piece of equipment was the purchase of a vein finder for the radiotherapy centre at Preston, costing £3,520, to help cannulations go more smoothly for patients.

Grants for medical equipment: £801k / 52%

Grants for patient environment and wellbeing: £314k / 21%

Grants for clinical research: £7k / 0%

Grants for staff education and wellbeing: £0k / 0%

Raising Funds: £289k / 19%

Charitable activity support costs: £115k / 8%

Annual Report 2024/2025

We spent £314k on patient welfare projects, aimed at supporting patient wellbeing and improving the hospital environment for patients and visitors. This financial year saw the opening of the new Chemotherapy Unit at Royal Blackburn Teaching Hospital; while the £80,000 that we gave towards this renovation had been agreed prior to this financial year, the balance of the funds were spent in this timeframe. The newly refurbished “Bluebell Unit” is now home to the acute oncology team and systemic anti-cancer therapy team, who are based together for the first time, and the unit will provide chemotherapy, immunotherapy and supportive treatments to cancer patients. It also has dedicated private rooms for patients and their loved ones.

This spend also included our support of Bowland House, at a cost of £40,000. Bowland House is a guest house type property that is located on site at the Royal Preston Hospital, which provides a free-of-charge place to stay for patients (and their relatives) who live too far away to commute daily for their care. Approximately half of the patients who stay at Bowland House are oncology patients from across the region, so it falls within our charitable remit to fund half of the running costs of the house.

We spent £24,252 on the creation of a quiet room at Blackpool Victoria Hospital, and we continued our long-standing agreements to support the provision of free-of-charge complementary therapies at Lancashire Teaching Hospitals, Blackpool Teaching Hospitals, and the University Hospitals of Morecambe Bay. We also agreed to support the continuation of the popular Radiotherapy Open Mornings at the cancer centre at a cost of £900 each, where cancer patients (and their loved ones) can see the department before they commence with their treatment. This gives them the opportunity to see treatment rooms, chat to staff, ask questions, and hopefully alleviate any anxiety they may have.

Smaller patient welfare projects funded included, as in previous years, the purchase of ice creams and the continuation of a Fruit Cocktail & Canape Service for patients on the Ribblesdale Ward at Royal Preston Hospital. We also supported refreshments at the Central Lancashire Breast Unit, and the continued provision

of iPods, speakers and a Spotify subscription for the Radiotherapy Department at Royal Preston to help make the patient environment more welcoming.

Our spend on clinical research projects was lower than normal in 2024-25 at just £7k, however we have committed to a number of promising, innovative research projects that will commence during the current and forthcoming financial years.

£289k was spent on raising funds, without

which, the Foundation would not be able to raise the significant sums it does to support its charitable objectives. Amongst other outgoings, this includes event and marketing costs and fundraising staff salaries. Fundraising professionals drive the charity’s fundraising plans and strategies, ensuring a maximum return on investment is achieved.

Commitments for the next financial year

Following a successful year of fundraising, we’re in a position to commit to funding a number of exciting and new projects during 2025/26. These projects will be decided during our next funding rounds, where applications will be welcomed for new equipment, patient welfare projects, local research and staff wellbeing and training initiatives.

The projects funded in the 2025/26 financial year will include a grant of £260,000 to fund a ThermoFisher Genexus and Purification Module for the pathology department at Blackpool Teaching Hospitals. This kit will drastically improve genomic testing for lung cancer patients, ensuring that patients will not miss out on treatment options, nor need repeat biopsies prior to commencing the treatment that best suits their need.

We have also committed a further £40,000 towards the continuation of the services that Bowland House provides for patients who have to stay away from home during their treatment.

Over the last few years we have diversified our fundraising income streams, actively supporting more fundraising via charitable trusts, further promoting legacy giving, and via digital means, as well as supporting the many third party and community events across the region.

We’ll continue to place a significant emphasis on supporter engagement and stewardship through our newsletters, impact reports, end-of-year mailings and acknowledgements, to ensure that supporters know how much we appreciate their kindness. We’ll also seek to enhance our increasingly high profile throughout Lancashire and South Cumbria by continuing to engage with the public, promoting ongoing and new charitable initiatives, projects, case studies and supporter led activities through the local press, social media, and other publications where appropriate.

During the year ahead, we will continue to review our governance and infrastructure to ensure it is aligned to the latest ideals of operational excellence, putting in place a sustainable platform for growth and enabling a more strategic approach to raising funds, and using those funds raised for the benefit of local cancer patients.

rosemei Chomothprapy Day Lknt £4JJ2 l. rOsemere.org￿k Itj

Structure

The Foundation follows the NHS Corporate Trustee operational model with members of Lancashire Teaching Hospitals NHS Foundation Trust Board being appointed as its Corporate Trustee. The Corporate Trustee members are appointed upon their appointment to the Board of Directors of Lancashire Teaching Hospitals NHS Foundation Trust.

The overall management and decision making of the Foundation is delegated by the Corporate Trustee to the Charitable Funds Committee and Management Committee.

Charitable Funds Committee

The Charitable Funds Committee meet quarterly and have specific terms of reference; no business may be transacted at a meeting unless two Non-Executive Directors and one Executive Director, who must be the Finance Director (or nominated deputy), are present.

The Charitable Funds Committee is responsible for reviewing and managing its Charitable Funds in accordance with the Trust’s Standing Financial Instructions and its scheme of delegated powers of authority.

The Charitable Funds Committee works within the delegated powers granted to it by the Corporate Trustee who retain the right to amend delegated powers and terms of reference as appropriate. As part of its delegated powers, it is responsible for the following:

The Committee is supported in doing so by the Head of Charities.

The Foundation operates within a framework with clear policies on investments, sponsorship, fundraising, expenditure and reserves. Authority to approve expenditure from funds is controlled through delegated limits.

Annual Report 2024/2025

Rosemere Management Committee

The Corporate Trustee delegates day to day responsibility for the running of The Rosemere Cancer Foundation to the Management Committee, under the direction of an independent Chairman. The Management Committee is comprised of non-executive members of the Trust Board, representatives from each of the four NHS Trusts within which the Foundation operates, including clinical staff and lay members.

The Funds

The Rosemere Cancer Foundation has a single unrestricted fund that is spent, as far as possible, in the optimum way to further the wider objectives of the charity.

Connected Parties and Linked Charities

The Charity holds 100% of the share capital in Rosemere Coffee Shop Limited (Company registration Number 07913994), a retail outlet based in the Rosemere Cancer Centre at Royal Preston Hospital. All gross profits are donated to the Charity under the Gift Aid scheme and the company’s accounts have been consolidated with the Charity’s accounts this financial year.

The Charity is linked to the separate registered charity, Lancashire Teaching Hospitals Charity (formerly Lancashire Teaching Hospitals NHS Foundation Trust Charity). It was established under the same declaration of trust in November 1995 and shares the same Corporate Trustee. The Charity pools its investments with that of Lancashire Teaching Hospitals Charity to form a single investment portfolio, resulting in greater efficiency in the management of the investments.

Risk Management and Internal Controls

Due to the close relationship between the Trust and the Foundation the risk management process is embedded into that of the Trust’s assurance framework and risk management systems.

The Board of Directors of the Trust, who are also the Corporate Trustee, have adopted a formal risk management process to assess business risk and implement risk management strategies. Senior management and the trustee have:

A risk register has been prepared to assist in managing risk to which the Trust has been exposed. The risk register is monitored by the Trust’s Governance framework who request regular updates on any the relevant action plans and ensure that all appropriate controls are in place or have been identified.

Principal risks and uncertainty facing the Foundation

As part of the business planning exercise carried out during the year, the Charitable Funds Committee has considered the major risks to which the Foundation is exposed. They have reviewed processes and identified steps to mitigate three risks that have been identified:

Annual Report 2024/2025

Future levels of income

The Foundation is reliant on donations to allow it to make grants to NHS bodies. If income falls, then the charity would not be able to make as many grants or enter into longer term commitments with the NHS bodies it supports.

Internal controls

The Corporate Trustee has overall responsibility for ensuring that the organisation operates an appropriate system of controls, financial and otherwise, to provide reasonable assurance that:

The Committee mitigates the risk that income will fall by engaging with the Head of Charities. They regularly review the events calendar to understand what is working well and how things could be done better, or to consider what new events could be introduced.

Fall in investment returns

The Foundation generates additional income from investing its cash, so a decline in market values resulting in the loss of investment income is considered to be a major financial risk.

This risk is mitigated by retaining expert investment managers and having a diverse portfolio that is regularly reviewed. The current category of risk for the portfolio is five (moderate). The Foundation’s reserves and investment policies on page 23 are designed to ensure that no unnecessary risks are taken.

Financial challenges in the region

The NHS, by its very nature, is subject to national changes in government policy as well as local politically driven decisions. The charity aims to support the NHS Trusts within the Lancashire and South Cumbria region, but they are all financially challenged and currently operating with financial deficits.

The committee are well aware of the challenges faced across the region and the Executives that sit on the Committee are able to provide an insight on any potential changes to services, to ensure this does not have any negative impact on the charity.

In this regard, the Corporate Trustee places reliance upon the Trust’s Audit Committee whose remit is to examine the effectiveness and appropriateness of the system of internal controls. This is achieved by:

The systems of financial control are designed to provide reasonable, but not absolute, assurance against material misstatement or loss. These include:

Trustee and Advisors and Contact Details for the Foundation

As the Foundation operates under a Corporate Trustee model, the names of the directors are required to be disclosed:

----- Start of picture text -----
Responsibility Name Post From To
Silas Nicholls Chief Executive Officer
Katie Foster-Greenwood Chief Operating Officer 12/08/2024
Emma Ince Interim Chief Operating Officer 10/06/2024 11/08/2024
Imran Devji Interim Chief Operating Officer 09/06/2024
Craig Carter Acting Chief Finance Officer 01/05/2025
David Stonehouse Interim Chief Finance Officer 02/09/2024 30/04/2025
Jonathan Wood Chief Finance Officer / Deputy Chief Executive 01/09/2024
Geraldine Skailes Chief Medical Officer
Sarah Morrison Chief Nursing Officer and Deputy Chief Executive
Officer from 1st October 2024)
Neil Pease Chief People Officer
Stephen Dobson Chief Information Officer 30/06/2024
Ailsa Brotherton Chief Strategy and Improvement Officer
Gary Doherty Director of Strategy and Planning 07/01/2025
Naomi Duggan Director of Communications and Engagement
Jennifer Foote Director of Corporate Affairs (SIRO) 01/10/2024
Jennifer Foote Company Secretary 30/09/2024
Angela Mulholland-Wells Operational Director of Finance 06/10/2024
Mike Thomas Chair 01/01/2025
Peter White Chair 31/12/2024
Paul O’Neill Vice Chair / Non-Executive Director 02/03/2025
Tim Watkinson Senior Independent Director 31/03/2025
Tim Ballard Non-Executive Director
Karen Deeny Non-Executive Director 01/03/2025
Adrian Leather Non-Executive Director 01/03/2025
John Schorah Non-Executive Director 01/03/2025
StJohn Crean Non-Executive Director 03/03/2025
Tim Wheeler Non-Executive Director 01/04/2025
Uzair Patel Non-Executive Director 01/07/2024
Uzair Patel Associate Non-Executive Director 01/07/2024
Michael Wearden Associate Non-Executive Director 09/06/2024
Peter Wilson Associate Non-Executive Director 15/06/2024
Victoria Crorken Non-Executive Director 07/02/2025
Kate Smyth Non-Executive Director 28/02/2025
Jim Whitaker Non-Executive Director 01/07/2024
Tricia Whiteside Non-Executive Director 28/02/2025
----- End of picture text -----

All members have been in post for the whole year unless otherwise stated.

Annual Report 2024/2025

Charitable Funds Committee members: 02/09/2024

----- Start of picture text -----
Responsibility Name Post From To
----- End of picture text -----

Non-Executive Director (Chair of the Committee) Tim Ballard 01/03/2025
Non-Executive Director (Chair of the Committee) Kate Smyth 28/02/25
Non-Executive Director Uzair Patel 01/03/2025
Non-Executive Director Tim Wheeler 01/03/2025
Chief Nursing Ofcer (Deputy Chief Executive Sarah Morrison
Ofcer from 01/10/2024)
Acting Chief Finance Ofcer Craig Carter 01/05/2025
Interim Chief Finance Ofcer David Stonehouse 02/09/2024 30/04/2025
Chief Finance Ofcer / Deputy Chief Executive Jonathan Wood 01/09/2024
Non-Executive Director Victoria Crorken 7/02/2025
Non-Executive Director Tricia Whiteside 8/02/2025

All members have been in post for the whole year unless otherwise stated.

Rosemere Management Committee members:

----- Start of picture text -----
Responsibility Name
----- End of picture text -----

Non-Executive Director Tim Watkinson Lancashire Teaching Hospitals NHS FT
Lead Clinician for Oncology Dani Bury Blackpool Teaching Hospitals NHS FT
Lead Cancer Nurse Jessica Jones Blackpool Teaching Hospitals NHS FT
Consultant Urologist Rosie Blades Lancashire Teaching Hospitals NHS FT
Lead Clinician for Cancer Kish Pursnani Lancashire Teaching Hospitals NHS FT
Lead Cancer Nurse Anne Tomlinson Lancashire Teaching Hospitals NHS FT
Consultant Therapeutic Radiographer Tracey Ellis Lancashire Teaching Hospitals NHS FT
Lead Cancer Clinician Tom Raymond University Hospital of Morecambe Bay
NHS FT
Lead Cancer Nurse Fiona MacDonald University Hospital of Morecambe Bay
NHS FT
Lead Clinician for Cancer Panayiotis Kyzas East Lancashire Hospitals NHS T
Lead Cancer Nurse Steph Hechter East Lancashire Hospitals NHS T
Head of Charities Daniel Hill Rosemere Cancer Foundation
Assistant Finance Director Bhimji Patel Lancashire Teaching Hospitals NHS FT
Volunteer Representative &Chair from John Hodgson Lay Member
Vice Chair Jacob Knowles Lay Member

Annual Report 2024/2025

Information

Registered Charity Number and name: 1131583 The Rosemere Cancer Foundation

Principal Office address Royal Preston Hospital Sharoe Green Lane Fulwood Preston PR2 9HT

Head of Charities

Daniel Hill e | Daniel.hill@lthtr.nhs.uk

The following advisors were retained by the Foundation in 2024/25:

Bankers

National Westminster Bank PLC 97 Fishergate Preston PR1 2AE

Auditors

Beever and Struthers The Beehive Lions Drive Shadsworth Business Park Blackburn BB1 2QS

Investment Advisors

Finance Office address: Preston Business Centre, Watling St Rd, Fulwood, Preston PR2 8DY

RBC Brewin Dolphin 1 The Avenue Spinningfields Square Manchester M3 3AP

Solicitors

Mills & Reeve 3 Symphony Park Manchester M1 7FS

21

The Charity’s annual accounts have been produced in accordance with FRS102 as were the previous years. Therefore, no adjusting entries were required for the comparative year.

The charity is reporting a surplus for the year before adjustments for market value gains and losses on investments of £20k. (2023/24: surplus of £58k) The investment portfolio has continued to experience volatility throughout the year due to international and economic factors. A decrease in market values, gave rise to an unrealised loss of £60k that is offset against an actual net gain on the sale of investments of £80k; resulting in a net gain on investments of £20k (2023/24: gain of £58k) for the year.

• Income from charitable activities of £527k has continued to grow in 2024/25. Another busy event calendar has generated £25k more than the previous year.

Support costs of £141k were £5k lower than 2023/24. This is due to small reductions in a number of areas. Net current assets of £1,401k were £249k higher at the end of the year compared to last year. This is primarily due to an increase in legacy debtors.

Total Charity funds at the end of the year were £291k higher than 2023/24 at a level of £1,891k required to fund the Charity’s outstanding commitments for various projects and items of equipment.

Incoming resources of £1,797k were £305k higher than 2023/24. This represents a 20% increase.

• Income from donations and legacies of £1,189k was £264k more than the previous year primarily due to an increase in legacies.

• Other trading income was £44k, £7k higher than 2023/24. This increase reflects the hard work of our Rosemere Coffee Shop volunteers.

• Investment income was £7k higher than last year, mostly due to an increase in dividends received and the charity receiving a higher share of the dividend income as per the apportionment, that is based on the balance of funds for the charities in the investment pool. Despite the reduction in bank interest rates a higher cash balance generated more bank interest than the previous year.

Annual Report 2024/2025

Going Concern

The trustee considers that there are no material uncertainties about The Rosemere Cancer Foundations’ ability to continue as a going concern. As a grant making charity with few on-going commitments, the trustee will continue to manage the amount of new grants in line with the reserves policy requirements. There are no material uncertainties affecting the current year’s accounts.

In future years, the key risks to the foundation are a fall in income from donations or investment income but the trustee has arrangements in place to mitigate those risks (see the risk management and reserves sections of the annual report for more information).

Reserves Policy

The charity has a reserves policy which was combined with the investment policy and reviewed in September 2022. The Charity has considered the level of reserves to be held for the prudent management of its working assets, commitments and contingencies.

Reserves are defined as funds that are freely available to fund the day-to-day operation of the charity and are not subject to commitments or other restrictions. The trustee requires that reserves are available to cover the following:

• Unrealised gains on investments recognised in the accounts

• Provision for short-term commitments and ongoing programmes and

• Six months of operating expenditure At the 31st March 2025 the Charity held total unrestricted reserves of £1,891k (2023/24: £1,600k). The total realised and unrealised gain recognised in 2024/25 is £20k (2023/24: gain £58k). This is the result of a gain on the sale of investments of £80k (2023/24: gain £3k) and a loss on the carrying value of the investments of £60k (2023/24: gain of £55k).

The Trustee aims to maintain free reserves in unrestricted funds at a level which equates to approximately six months of operating expenditure £197k. The Trustee considers that this level will provide sufficient funds to respond to delays or changes in applications for grants and to ensure that support and governance costs are covered.

The Charity currently has commitments of £535k to be funded from unrestricted reserves. The value of reserves held after making allowances for these commitments and 6 months operating costs is £1,159k.

The level of reserves is continually monitored by the Trustee and the policy will be reviewed at least every three years.

Investment Policy

The policy is reviewed every three years; it was last reviewed at the Charitable Funds Committee meeting that took place in September 2022.

The Charity’s investments are held in stocks and shares and are managed by a well-respected investment management company, Brewin Dolphin. The Trust maintains a strict control over investments, laying down a well-structured framework within which Brewin Dolphin must operate in order to minimise the risks associated with investments.

Overseas equities should not exceed 15% of the total holding of equities and investments in negotiable instruments known as “derivatives” are not permitted in any circumstances.

Investment in tobacco, alcohol and armaments is prohibited. If it should come to light that a company has become involved in unethical practices the Corporate Trustee should be consulted with a view to selling the investment.

The market value of managed funds shall not exceed 75% of the total charitable fund reserves.

The Corporate Trustee are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and United Kingdom Accounting standards (United Kingdom Generally Accepted Accounting Practice). They are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the Charity and enable them to ensure that financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the Trust Deed. They are also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The law applicable to charities in England and Wales requires the Trustee to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the Charity and of the incoming resources and application of resources of the Charity for the period. In preparing these financial statements, the Trustee is required to:

The Corporate Trustee is responsible for the maintenance and integrity of the Charity and financial information. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

The Corporate Trustee confirms that there is no relevant audit information of which the Charity’s auditors are unaware and they have taken all steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the Charity’s auditors are aware of that information. By order of the Corporate Trustee

Signed:

Mike Thomas Sarah Morrison

Chair Trustee Date: Date:

24 O

16/09/2025

16/09/2025

Independent Auditor’s Report to the trustee of The Rosemere Cancer Foundation.

Opinion

We have audited the financial statements of The Rosemere Cancer Foundation “the parent charity” and its subsidiary “the group” for the year ended 31 March 2025 which comprise the Consolidated Statement of Financial Activities, the Consolidated Balance Sheet, the Parent Balance Sheet, the Consolidated Cash Flow Statement and the related notes. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (United Kingdom Generally Accepted Accounting Practice).

We have been appointed as auditor under section 144 of the Charities Act 2011 and report in accordance with the Act and relevant regulations made or having effect thereunder.

In our opinion, the financial statements:

• give a true and fair view of the state of the charity’s affairs as at 31 March 2025 and of its incoming resources and application of resources, including its income and expenditure for the year then ended;

Basis for opinion

We conducted our audit in accordance with International Standards on auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Annual Report 2024/2025

Conclusions relating to going concern

We have nothing to report to you in respect of the following matters in relation to which the ISAs (UK) require us to report to you were:

• the trustee has not disclosed in the financial statements any identified material uncertainties that may cast significant doubt about the group’s or the parent charity’s ability to continue to adopt the going concern basis of accounting for a period of at least twelve months from the date when the financial statements are authorised for issue.

Other information

The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. The trustee is responsible for the other information. Our opinion on the financial statements does not cover the other information and, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information; we are required to report that fact.

We have nothing to report in this regard.

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters in relation to which the Charities (Accounts and Reports) Regulations 2008 require us to report to you if, in our opinion:

Annual Report 2024/2025

Responsibilities of trustees

As explained more fully in the Corporate Trustee Responsibilities Statement set out on page 24, the trustee is responsible for the preparation of the group and parent charity financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine what is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the Trustee is responsible for assessing the group’s and the parent charity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Trustee either intends to liquidate the group or the parent charity or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

We have been appointed as auditor under section 144 of the Charities Act 2011 and report in accordance with the Act and relevant regulations made or having effect thereunder.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s web-site at www.frc.org. uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Use of our report

This report is made solely to the parent charity’s Trustee, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. Our audit work has been undertaken so that we might state to the charity’s trustee those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charity and the charity’s trustees as a body, for our audit work, for this report, or for the opinions we have formed.

Beever and Struthers, Statutory Auditor

Beever and Struthers is eligible to act as auditor of the charity by virtue of its eligibility for appointment as auditor of a company under section 1212 of the Companies Act 2006.

S Lomax FCA

(Senior Statutory Auditor)

For and on behalf of Beever and Struthers

The Beehive Lions Drive, Shadsworth Business Park, Blackburn, BB1 2QS Date: 23 September 2025

Consolidated Statement of Financial Activities for the year ended 31 March 2025


2025
2024/2025 2023/2024
Notes Unrestricted Total Unrestricted Restricted
Funds Funds Funds Funds
£000 £000 £000 £000
Income and endowments from:
Donations and legacies 3.1 1,189 1,189 925 925
Charitable activities 3.2 527 527 502 502
Other trading activities 3.3 44 44 35 35
Investments 3.4 37 37 30 30
Total incoming resources 1,797 1,797 1,492 1,492
Expenditure on:
Raising funds 4 289 289 266 266
Charitable activities 5 1,237 1,237 1,245 1,245
Total expenditure 1,526 1,526 1,511 1,511
Net gain on investments 11.2 20 20 58 58
Net income/ (Expeniture) 291 291 39 39
Net movement in funds 18 291 291 39 39
Reconciliation of Funds
Total funds brought forward 18 1,600 1,600 1,561 1,561
Total Funds carried forward 18 1,891 1,891 1,600 1,600

Annual Report 2024/2025

Consolidated Balance Sheet as at 31 March 2025

Unrestricted Total at 31 Total at 31
Notes Funds March 2025 March 2024
£000 £000 £000
Fixed Assets
Tangible assets 10 2 2 2
Investments 11 488 488 446
Total Fixed Assets 490 490 448
Current Assets
Inventories 13 5 5 5
Debtors 14 380 380 6
Cash and cash equivalents 15 1,302 1,302 1,316
Total Current Assets 1,687 1,687 1,327
Liabilities
Creditors falling due within one year 17 286 286 175
Net Current Assets 1,401 1,401 1,152
Total Assets less Current Liabilities 1,891 1,891 1,600
Total Net Assets 1,891 1,891 1,600
The Funds of the Charity
Unrestricted income funds 18 1,891 1,891 1,600
Total Charity Funds 1,891 1,891 1,600

The financial statements on pages 28 to 43 were approved and authorised for issue by the Board of Trustees on the 16th September 2025 and approved on its behalf by the Charitable Funds Committee.

Signed:

Date: 16/09/2025

29 O

Annual Report 2024/2025

Parent Balance Sheet as at 31 March 2025

Notes Unrestricted Total at 31 Total at 31
Funds March 2025 March 2024
£000 £000 £000
Fixed Assets
Investments 11 488 488 446
Total Fixed Assets 488 488 446
Current Assets
Debtors 14 391 391 17
Cash and cash equivalents 15 1,250 1,250 1,274
Total Current Assets 1,641 1,641 1,291
Creditors falling due within one year 17 279 279 168
Net Current Assets 1,362 1,362 1,123
Total Assets less Current Liabilities 1,850 1,850 1,569
Total Net Assets 1,850 1,850 1,569
The Funds of the Charity
Unrestricted income funds 18 1,850 1,850 1,569
Total Charity Funds 1,850 1,850 1,569

The unrestricted funds are used to fund activities in furtherance of the foundation’s objectives. The table above shows the consolidated funds position. This included the funds from the subsidiary company which in 2024/25 were £41,000 (2023/24: £31,000).

Signed:

Date: 16/09/2025

30 O

Annual Report 2024/2025

Consolidated Cash Flow Statement for the year ended 31 March 2025

Cash fows from operating activities:
Net cash (used) / provided in operating activities
Cash fows from investing activities:
Interest received
Dividends received
Proceeds from sale of investments
Purchase of investments
Net cash provided by investing activities:
Change in cash and cash equivalents in the reporting period
Cash and cash equivalents at the beginning of the reporting period
Cash and cash equivalents at the end of the reporting period
Notes
19
3.4
3.4
11.1
11.1
16		 Total at 31
Total at 31
March 2024
March 2023
£000
£000
(29)
(489)
14
13
23
17
235
241
(257)
(259)
15
12
(14)
(477)
1,316
1,793
1,302
1,316

1. Accounting policies

1.1 Basis of preparation

The financial statements of the charity are presented in £ Sterling, rounded to the nearest thousand and have been prepared under the historical cost convention, with the exception of investments which are included at fair value.

The financial statements have been prepared in accordance with the Accounting and Reporting by Charities: Statement of Recommended Practice applicable to Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2015) - Charities SORP (FRS102), the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS102) and the Charities Act 2011.The Charity constitutes a public benefit entity as defined by FRS102.

1.2 Going concern

The trustee considers that there are no material uncertainties about The Rosemere Cancer Foundations’ ability to continue as a going concern. As a grant making charity with few on-going commitments, the trustee will continue to manage the amount of new grants in line with the reserves policy requirements. There are no material uncertainties affecting the current year’s accounts.

In future years, the key risks to the foundation are a fall in income from donations or investment income but the trustee has arrangements in place to mitigate those risks (see the risk management and reserves sections of the annual report for more information).

information).

The key judgements are those policies relating to incoming resources (notes 1.7 and 1.8), recognition of expenditure and associated liabilities as a result of grant (note 1.11) and fixed asset investments (note 1.16). The Trustee does not consider there are any sources of estimation uncertainty requiring disclosure beyond the accounting policies listed below.

1.4 Key estimations

The value of potential legacies disclosed in note 20. Contingent assets and liabilities is estimated using information received from solicitors and current property market valuations.

1.5 Funds structure

Where there is a legal restriction on the purpose to which a fund may be put, the fund is classified as a restricted fund or an endowment fund.

Restricted funds are those where the donor has provided for the donation to be spent in furtherance of a specified charitable purpose. Endowment funds arise when the donor has expressly provided that the gift is to be invested and only the income of the fund may be spent.

Those funds which are neither endowment nor restricted income funds are unrestricted income funds which can be analysed between designated (earmarked) funds where the trustees have set aside amounts to be used for specific purposes or which reflect the nonbinding wishes of donors, and unrestricted funds which are at the trustees’ discretion.

1.3 Critical judgements in applying accounting policies

In future years, the key risks to the foundation are a fall in income from donations or investment income but the trustee has arrangements in place to mitigate those risks (see the risk management and reserves sections of the annual report for more

The Rosemere Cancer Foundation has no restricted funds and only one unrestricted fund. The restricted fund that was created in April 2022 for the creation of the 25th Anniversary Appeal was closed in the same financial year (2022/23) as the appeal target was reached.

Annual Report 2024/2025

1.6 Basis of consolidation

The group financial statements consolidate the results of the Foundations’ trading subsidiary, The Rosemere Coffee Shop Ltd, on a line by line basis. Advantage has been taken of the SORP and the parent charity’s own income and expenditure has not been disclosed in these financial statements. The income of The Rosemere Cancer Foundation was £1,797k (2023/24: £1,492k), giving rise to a surplus of £291k (2023/24: surplus £39k).

Subsidiary companies are exempt from the requirement of the Companies Act 2006 relating to the audit of the individual accounts by virtue of S479A.

1.7 Incoming resources

All incoming resources are recognised once the charity has entitlement to the resources, it is probable that the resources will be received and the monetary value of the incoming resources can be measured with sufficient reliability. Gifts in kind are recognised as a reasonable estimate of their fair value or the amount actually realised.

Where there are terms or conditions attached to incoming resources, particularly grants, then these terms or conditions must be met before the income is recognised as the entitlement condition will not be satisfied until that point. Where terms or conditions have not been met or uncertainty exists as to whether they can be met then the relevant income is not recognised in the year but deferred and shown on the balance sheet as deferred income.

1.8 Incoming resources from legacies

Legacies are accounted for as incoming resources either upon receipt or where the receipt of the legacy is probable. Receipt is probable when:

If there is uncertainty as to the amount of the legacy and it cannot be reliably estimated, then the legacy is shown as a contingent asset until all of the conditions for income recognition are met.

measured, they will be included in the accounts when they are sold and the amount actually realised. Donated services are measured and included in the accounts on the basis of the value of the gift to the charity. i.e. what the charity would pay in the open market for the services that are being donated.

1.10 Resources expended and irrecoverable VAT

All expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all costs related to each category of expense shown in the Statement of Financial Activities. Expenditure is recognised when the following criteria are met:

Irrecoverable VAT is charged against the category of resources expended for which it was incurred.

1.11 Recognition of expenditure and associated liabilities as a result of grant

Grants payable are payments made to linked, related party or third-party NHS bodies and non-NHS bodies, in furtherance of the charitable objectives of the funds held on trust, primarily relief of those who are sick.

Grant payments are accounted for on an accruals basis where the conditions for their payment have been met or where a third party has a reasonable expectation that they will receive the grant.

The trustee has control over the amount and timing of grant payments and consequently where approval has been given by the charitable funds committee, on behalf of the trustee, grants are considered commitments. An appropriate designation is made for these commitments in the appropriate fund until payment is due to be made at which point the expenditure and liability is recognised in the accounts. Approved commitments of expected future expenditure are disclosed in note 21.

1.12 Allocation of support costs and overheads

Support costs are those costs which do not relate directly to a single activity, including governance costs, that are costs which relate to the strategic as opposed to the day to day management of a charity.

1.9 Gifts in kind and donated services

Gifts in kind are recognised as a reasonable estimate of their fair value or where the monetary value of gifts cannot be reliably

Support costs include some staff costs, costs of administration and external audit costs. They have been

Annual Report 2024/2025

apportioned between the cost of raising funds and charitable activities on the basis of expenditure incurred in relation to each category. The analysis of support costs and the apportionment is shown in note 7.

1.13 Fundraising costs

The costs of generating funds are those costs attributable to generating income for the charity, other than those costs incurred in undertaking charitable activities or the costs incurred in undertaking trading activities in furtherance of the charity’s objects. The costs of generating funds represent fundraising costs together with investment management fees. Fundraising costs include expenses for fundraising activities and salaries and overhead costs paid to a related party, Lancashire Teaching Hospitals NHS Foundation Trust, shown in note 2.

Quarterly management fees are offset against commission charges. Fees that exceed the commission charge are deducted from the funds on deposit are shown in note 4.

1.14 Charitable activities

Costs of charitable activities comprise all costs incurred in the pursuit of the charitable objects of the charity. These costs, where not wholly attributable, are apportioned between the categories of charitable expenditure in addition to the direct costs. The total costs of each category of charitable expenditure include an apportionment of support costs as shown in note 5.

1.15 Tangible fixed assets

Equipment assets are carried at depreciated historic cost, as this is not considered to be materially differentfrom fair value.

The Rosemere Coffee Shop has equipment assets that are depreciated on a reducing balance basis at 15% inorder to write them off over their remaining useful life, in a manner which reflects the consumption of economic benefit or service potential of the assets.

1.16 Fixed asset investments

Investments are a form of basic financial instrument and are initially recognised at their transaction value and subsequently measured at their fair value (market value) as at the balance sheet date using the quoted market bid price. The Statement of Financial Activities includes the net gains and losses arising on revaluation and disposals throughout the year.

The main form of financial risk faced by the charity is that of volatility in equity markets and investment markets due to wider economic conditions, the attitude of investors to investment risk, and changes in sentiment concerning equities and within particular sectors or sub sectors.

All realised and unrealised gains and losses are combined in the Statement of Financial Activities and are taken as they arise. Realised gains and losses on investments are calculated as the difference between sales proceeds and opening carrying value or their purchase value, if acquired subsequent to the first day of the financial year. Unrealised gains and losses are calculated as the difference between the fair value at the year end and their carrying value.

1.17 Inventories

Inventories are valued at the lower of cost and net realisable value.

1.18 Debtors

Debtors are amounts owed to the foundation. They are measured on the basis of their recoverable amount. Prepayments are valued at the amount prepaid.

1.19 Cash and cash equivalents

Cash at bank and in hand is held to meet the day to day running costs of the charity as they fall due. Cash equivalents are short term, highly liquid investments, held in interest bearing savings accounts.

Annual Report 2024/2025

1.20 Creditors

Creditors and provisions are amounts owed by the foundation. They are recognised when the Foundation has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount.

Amounts which are owed in more than a year are shown as long term creditors.

1.21 Financial instruments

Financial assets and financial liabilities are recognised when the Foundation becomes a party to the contractual provisions of the instrument. All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

The foundation only holds financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.

1.22 Remuneration and benefits

No staff are directly employed by the Foundation. All staff engaged in the activities of the Foundation are employed by Lancashire Teaching Hospitals NHS Foundation Trust. The Foundation is recharged for individuals time spent engaged in either charitable activities, raising funds or providing support (e.g. back office functions) to the Foundation.

2. Related party transactions

The Rosemere Cancer Foundation is managed by the Corporate Trustee which is also the Board of Directors of Lancashire Teaching Hospitals NHS Foundation Trust which is the main beneficiary of the Foundation. During the year the Foundation made revenue and capital payments to Lancashire Teaching Hospitals NHS Foundation Trust of £1,276k (2023/24: £1,441k), including grants of £1,086k (2023/24: £608k).

The Foundation was recharged £279k (2023/24: £278k) for staff that worked for the Foundation throughout the year, whose contracts are paid by Lancashire Teaching Hospitals NHS Foundation Trust. This includes accounting and administrative support provided to the Foundation at a cost of £21k (2023/24: £23k).

During the year none of the Trustees or members of the key management staff or parties related to them, have undertaken any material transactions with The Rosemere Cancer Foundation or received any benefit from the foundation in payment in kind. (2023/24: £nil).

As at 31 March 2025 £83k was owed by Lancashire Teaching Hospitals NHS Foundation Trust to Rosemere Cancer Foundation (2023/24: £90k) was owed to Lancashire Teaching Hospitals NHS Foundation Trust.

The Trustee purchased trustee indemnity insurance at a cost of £3k. (2023/24: £3k).

The Foundations’ investment portfolio is pooled with that of Lancashire Teaching Hospitals Charity. The Foundation receives an apportionment of the income and expenditure related to the investments based on its share (31%) of the portfolio (2023/24: 30%).

All recharged staff members belong to the NHS Pension Scheme which is an unfunded defined benefit scheme, accounted for as a defined contribution scheme. The recharge from Lancashire Teaching Hospitals NHS Foundation Trust includes the employer contributions to that scheme. For more information on the NHS Pension Scheme refer to the Lancashire Teaching Hospitals NHS Foundation Trust annual report and accounts.

Annual Report 2024/2025

3. Incoming resources

3.1 Income from donations and legacies

3.1 Income from donations and legacies
Donations
Corporate donations
Legacies
Grants
Total		 Unrestricted
2024/2025
Funds
Total
£000
£000
311
311
51
51
787
787
40
40
1,189
1,189		 2023/2024
Total
£000
313
142
416
54
925

Donations of goods £29k (2023/24: £32k) are included in income valued at their market value. All of these donations have been distributed during the year.

3.2 Charitable activities income

3.2 Charitable activities income
Community Fundraising Groups
Events
Merchandise
Others
Total		 Unrestricted
2024/2025
Funds
Total
£000
£000
276
276
215
215
13
13
23
23
527
527		 2023/2024
Total
£000
306
162
14
20
502

Comparatives of charitables activities income have been restated to provide analysis of the material components as per the requirements of the SORP.

3.3 Income from other trading activities

Rosemere Coffee Shop Ltd sales
3.4 Investment income
Dividend income
Bank account interest
Total		 Unrestricted
2024/2025
Funds
Total
£000
£000
44
44
Unrestricted
2024/2025
Funds
Total
£000
£000
23
23
14
14
37
37		 2023/2024
Total
£000
35
2023/2024
Total
£000
17
13
30

Annual Report 2024/2025

4. Analysis of expenditure on raising funds

Fundraising team
Fundraising activities
Advertising / marketing
Trading activities
Investment management fees
Support costs
Total		 Unrestricted
2024/2025
Funds
Total
£000
£000
169
169
32
32
55
55
3
3
4
4
26
26
289
289		 2023/2024
Total
£000
163
22
49
4
3
25
266

5. Analysis of expenditure on charitable activities

The charity pursued its charitable activities by making grants. Support costs have been apportioned across the categories of charitable expenditure on the basis of the number of individual transactions and the associated transaction cost incurred by the charity, disclosed in note 7.

7.
Patient Environment and Wellbeing
Staff Education and Wellbeing
Research
Medical Equipment
Total		 Grant funded
Support
2024/2025
Activity
Total
Total
£000
£000
£000
314
32
346
-
-
-
7
-
7
801
83
884
1,122
115
1,237		 Grant funded
Support
2023/2024
Activity
Costs
Total
£000
£000
£000
227
24
251
12
1
13
110
12
122
775
84
859
1,124
121
1,245

Grants were approved to carry out activities that will benefit patients and their families. The charity incurred expenditure with third parties in pursuance of those grants.

6. Analysis of grants

The Foundation does not make grants to individuals. All grants are made to the Lancashire Teaching Hospitals NHS Foundation Trust or other institutions to provide care of NHS patients in furtherance of our charitable aims. The total cost of making grants, including support costs is shown on the face of the Statement of Financial Activities and the actual disbursement for each category of charitable activity is disclosed in note 5.

Institutions receiving grant support:
Lancashire Teaching Hospitals NHS FT
Blackpool Teaching Hospitals NHS FT
University Hospitals of Morecambe Bay NHS FT
East Lancashire Hospitals NHS Trust
Total amount paid		 2024/2025
Total
£000
1,086
8
27
1
1,122		 2023/2024
Total
£000
608
380
84
52
1,124

Annual Report 2024/2025

7. Allocation of support costs and overheads

Support and overhead costs are allocated between fundraising activities and charitable activities. Governance costs are those support costs which relate to the strategic rather than day to day management of the foundation. These costs are apportioned across the activities on the basis of expenditure incurred in relation to each category.

7.1 Analysis of total support costs

7.1 Analysis of total support costs
Financial Administration
Professional fees
Administration costs
Salary recharges
External Audit
Subscriptions / memberships
Total
Governance costs
Support costs
Total		 Raising
funds
£000
4
1
-
17
2
2
Charitable
2024/2025

Activities
Total

£000
£000

17
21

6
7

1
1

73
90

9
11

9
11

115
141
Unrestricted
2024/2025
Funds
Total
£000
£000
40
40
101
101
141
141		 Raising
Charitable
2023/2024
funds
Activities
Total
£000
£000
£000
4
19
23
1
7
8
-
2
2
16
75
91
2
11
13
2
7
9
26 25
121
146
2023/2024
Total
£000
50
96
146

7.2 Auditor’s remuneration

Total Audit Fees for 2024/25 were £11,250 (excluding VAT) which related solely to the audit with no additional work undertaken (2023/24: £10,610 (excluding VAT)). The audit fee is included within governance costs.

7.3 Support cost allocation

Raising Funds
Charitable Activities
Total		 Unrestricted
2024/2025
Funds
Total
£000
£000
26
26
115
115
141
141		 2023/2024
Total
£000
25
121
146

Annual Report 2024/2025

8. Trustee remuneration, benefits and expenses

The members of Lancashire Teaching Hospitals NHS Foundation Trust board give their time freely and receive no remuneration for the work that they undertake in relation to the charity. No expense claims were reimbursed to members of the board, by the charity in 2024/25. (2023/24: £nil). For more information on the Board members remuneration refer to the Lancashire Teaching Hospitals NHS Foundation Trust annual report and accounts.

9. Analysis of staff costs and remuneration of key management personnel


personnel
Salaries and wages
Social Security cost
Employer contributions
Total
Fundraising
Finance Support
Administration Support
Total		 2024/2025
£000
219
30
31
280
169
21
90
280		 2023/2024
£000
217
30
31
278
164
23
91
278

All staff engaged in the activities of the Foundation are employed by Lancashire Teaching Hospitals NHS Foundation Trust. No staff are directly employed by the charity.

The average number of full-time and part-time employees during the year was 2 and 5 respectively (2023/24: 4/2), an estimated number of full-time equivalent employees of 5 (2023/24: 5). These employees are involved in fundraising and providing support to the charitable activities or the governance of the foundation.

The Rosemere Cancer Foundation considers its key management personnel to be the member of the Lancashire Teaching Hospitals NHS Foundation Trust board, acting on behalf of the corporate trustee and the Head of Charities. The total employment benefits included employer pension contributions of the key management personnel were £34k (2023/24: £24k).

No employees had emoluments in excess of £60k (2023/24: £60k).

Annual Report 2024/2025

10. Tangible fixed assets - Group and Parent

10. Tangible fxed assets - Group and Parent

£000
Gross Cost as at 1 April
Additions
Gross cost at 31 March
Accumulated depreciation as at 1 April
Provided during the year
Accumulated depreciation at 31 March
Net book value at 31 March
Net book value at 1 April		 2024/2025
£000
9.7
0.3
10.0
7.5
0.3
7.8
2.2
2.1		 2023/2024
£000
9.7
0.0
9.7
7.2
0.4
7.6
2.1
2.5

11. Fixed asset investments - Group and Parent

11. Fixed asset investments - Group and Parent
11.1 Movement in fxed asset investments
Market value brought forward
Add : acquisitions at cost
Less: disposals at carrying value
Realised and unrealised gain / (loss) for the year
Market value at 31 March
Historic cost
11.2 Total gains / losses on investments
Unrealised (loss) / gain on carrying value of the investments
Gain / (loss) on sale of investments
Net gain on investments for the year
11.3 Fixed asset investments by type
Listed equity investments
Fixed interest investments
Other investment funds
Total market value		 2024/2025
£000
446
257
(235)
20
488

899
2024/2025
£000
(60)
80
20
2024/2025
£000
128
248
112
488		 2023/2024
£000
370
259
(241)
58
446
728
2023/2024
£000
55
3
58
2023/2024
£000
111
228
107
446

The foundation manages these investment risks by retaining expert advisors and operating an investment policy that provides for a high degree of diversification of holdings within investment asset classes. All investments were made in companies listed on a UK stock exchange or incorporated in the UK and therefore all investments are treated as investment assets in the UK.

Annual Report 2024/2025

12. Subsidiaries

Rosemere Coffee Shop Limited (07913994) was incorporated on 18th January 2012 and is wholly owned by The Rosemere Cancer Foundation and is engaged in the catering trade. Details of its trading activities are set out below.

12.1 Subsidiary results

12.1 Subsidiary results
Income
Costs
Net proft
Retained in subsidiary at beginning of year
Amount gif aided to The Rosemere Cancer Foundation
Retained in subsidiary		 2024/2025
£000
81
(40)
41
31
(31)
41		 2023/2024
£000
67
(36)
31
9
(9)
31

12.2 Summarised balance sheet of subsidiary trading company

Fixed Assets
Inventories
Cash and cash equivalents
Creditors: amounts falling due within one year
Creditors: amounts falling due afer more than one year
Total net assets
Capital and reserves		 2024/2025
£000
2
5
52
(7)
(11)
41
41		 2023/2024
£000
2
5
42
(7)
(11)
31
31

These accounts have been prepared by McMillan & Co LLP, Chartered Accountants, 28 Eaton Avenue, Matrix Office Park, Buckshaw Village, Chorley, PR7 7NA.

The £41k profit retained in the subsidiary will be gift aided to the charity post year end.

13. Inventories

Inventories comprise finished goods held for resale

13. Inventories
Inventories comprise fnished goods held for resale
Total
14. Analysis of debtors		 Group
2024/2025
2023/2024
£000
£000
5
5		 Parent
2024/2025
2023/2024
£000
£000
-
-
14. Analysis of debtors
Amounts falling due within one year.
Debtors
Legacy Debtors
Accrued income
Prepayments
Loan due from subsidiary undertaking
Total		 Group
2024/2025
2023/2024
£000
£000
83
-
280
-
13
3
4
3
-
-
380
6		 Parent
2024/2025
2023/2024
£000
£000
83
-
280
-
13
6
4
-
11
11
391
17

The debtor figure represents the sum owed at the end of the year by the trust a related party, Lancashire Teaching Hospitals NHS Foundation Trust £83K . There are no debtors falling due after more than one year

Annual Report 2024/2025

15. Analysis of cash and cash equivalents

Charity bank account
Subsidiary bank account
Stockbroker deposit account
Total
16. Analysis of changes in net debt
Cash and Cash equivalents
Total		 Group
2024/2025
2023/2024
£000
£000
1,249
1,271
52
42
1
3
1,302
1,316
At 1 April
Cash fows
2023
£000
£000
1,316
(14)
1,316
(14)		 Parent
2024/2025
2023/2024
£000
£000
1,249
1,271
-
-
1
3
1,250
1,274
At 31 March
2024
£000
1,302
1,302

17. Analysis of creditors

17. Analysis of creditors
Amounts falling due within one year.
Creditors
Social Security and other taxes
Accruals and deferred income
Total		 Group
2024/2025
2023/2024
£000
£000
7
92
-
3
279
80
286
175		 Parent
2024/2025
2023/2024
£000
£000
-
89
-
-
279
79
279
168

18. Analysis of charitable funds movements

Balance Incoming Resources Gains and Balance
At 31 March Resources Expended Losses At 31 March
2024 2025
£000 £000 £000 £000 £000
Unrestricted funds 1,600 1,797 (1,526) 20 1,891
1,600 1,797 (1,526) 20 1,891

The unrestricted funds are used to fund activities in furtherance of the foundation’s objectives.

Annual Report 2024/2025

19. Reconciliation of net income/(expenditure) to net cash flow from operating activities


from operating activities
Net income / expenditure for 2024/25 (as per the SOFA)
Depreciation
(Gain) on investments
Dividends, interest and rents from investments
(Increase) in inventories
Decrease / (increase) in debtors
(Decrease) / increase in creditors
Net cash (used) / provided in operating activities
20. Contingent assets and liabilities
Legacies		 2024/2025
£000
291
-
(20)
(37)
-
(374)
111
(29)
2024/2025
£000
49		 2023/2024
£000
39
1
(58)
(30)
(2)
-
(439)
(489)
2023/2024
£000
774

The charity has been notified of its entitlement to various legacies with an estimated value of £49k. However, the legacies have not been recognised in the financial statements as income as they do not meet the recognition criteria, being subject to conditions outside the charity’s control at the reporting date. The legacies will be recognised when the amounts of the legacies can be measured reliably.

21. Commitments

The Charity has the following outstanding commitments at the end of the year as they have made a provisional agreement to fund various projects and items of equipment. These have not been accounted for in the SOFA.

Total commitments outstanding as at 31 March 2025 2024/2025
£000
535		 2023/2024
£000
749

As described in note 6, the foundation awards a number of grants in the year. Included in commitments are many grants that are awarded and expected to be paid out in the next financial year as well as number of multi-year grants; those that relate to research and development or for funding specific posts will be paid over a longer period.

As the foundation has control over the award and timing of payment of grants, they remain commitments until there is certainty about the payment that will be funded from existing and future reserves.

22. Events after the reporting period

There are no adjusting events after the reporting period. However, it should be noted that these accounts have not been consolidated into the main accounts of Lancashire Teaching Hospitals NHS Foundation Trust due to materiality.

The £41k profit retained in the subsidiary will be gift aided to the charity post year end.

Annual Report 2024/2025 Notes 44

Annual Report 2024/2025 Notes 45

Annual Report 2024/2025 Notes 46

Annual Report 2024/2025 Notes 47

J)rosemere CANCER FOU NOA TIO Reg Cttanly No 1131553